載入...
L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
L-3,4-dihydroxyphenylalanine (L-DOPA) has been successfully used in the treatment of Parkinson’s disease (PD) for more than 50 years. It fulfilled the criteria to cross the blood–brain barrier and counteract the biochemical defect of dopamine (DA). It remarkably worked after some adjustments in line...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6981630/ https://ncbi.nlm.nih.gov/pubmed/31906250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21010294 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|